Literature DB >> 19843974

Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization.

Mae M Huang1, David H Overstreet, Darin J Knapp, Robert Angel, Tiffany A Wills, Montserrat Navarro, Jean Rivier, Wylie Vale, George R Breese.   

Abstract

In abstinent alcoholics, stress induces negative affect-a response linked to craving and relapse. In rats, repeated stresses at weekly intervals before 5-day ethanol diet sensitize withdrawal-induced anxiety-like behavior ("anxiety") that is blocked by a corticotrophin-releasing factor 1 (CRF-1)-receptor antagonist. Current experiments were performed to identify brain sites that support CRF involvement in stress sensitization of ethanol withdrawal-induced anxiety-like behavior. First, different doses of CRF microinjected weekly into the central amygdala (CeA) before ethanol exposure produced a dose-related sensitization of anxiety during ethanol withdrawal. Subsequently, CRF microinjection into the basolateral amygdala, dorsal raphe nucleus (DRN), or dorsal bed nucleus of the stria terminalis (d-BNST) also sensitized ethanol withdrawal-induced anxiety. In contrast, sensitization of ethanol withdrawal-induced anxiety was not observed after weekly CRF administration into the ventral-BNST, CA1-hippocampal region, or hypothalamic-paraventricular nucleus. Then, experiments documented the CRF receptor subtype responsible for CRF and stress sensitization of withdrawal-induced anxiety. Systemic administration of a CRF-1 receptor antagonist before CRF microinjection into the CeA, DRN, or d-BNST prevented CRF-induced sensitization of anxiety during ethanol withdrawal. Furthermore, repeated microinjections of urocortin-3, a CRF-2 receptor agonist, into the CRF-positive sites did not sensitize anxiety after withdrawal from ethanol. Finally, microinjection of a CRF-1 receptor antagonist into the CeA, DRN, or d-BNST before stress blocked sensitization of anxiety-like behavior induced by the repeated stress/ethanol withdrawal protocol. These results indicate that CRF released by stress acts on CRF-1 receptors within specific brain regions to produce a cumulative adaptation that sensitizes anxiety-like behavior during withdrawal from chronic ethanol exposure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843974      PMCID: PMC2802475          DOI: 10.1124/jpet.109.159186

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  50 in total

1.  Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study.

Authors:  E B De Souza; T R Insel; M H Perrin; J Rivier; W W Vale; M J Kuhar
Journal:  J Neurosci       Date:  1985-12       Impact factor: 6.167

Review 2.  Kindling as a model for alcohol withdrawal syndromes.

Authors:  J C Ballenger; R M Post
Journal:  Br J Psychiatry       Date:  1978-07       Impact factor: 9.319

3.  The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs.

Authors:  S E File
Journal:  J Neurosci Methods       Date:  1980-06       Impact factor: 2.390

4.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

5.  Characterization of rat hypothalamic corticotropin-releasing factor.

Authors:  J Rivier; J Spiess; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

6.  Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence.

Authors:  Glenn R Valdez; Eric P Zorrilla; Amanda J Roberts; George F Koob
Journal:  Alcohol       Date:  2003-02       Impact factor: 2.405

7.  Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study.

Authors:  L W Swanson; P E Sawchenko; J Rivier; W W Vale
Journal:  Neuroendocrinology       Date:  1983       Impact factor: 4.914

8.  Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study.

Authors:  S Cummings; R Elde; J Ells; A Lindall
Journal:  J Neurosci       Date:  1983-07       Impact factor: 6.167

9.  Characterization of susceptibility to audiogenic seizures in ethanol-dependent rats after microinjection of gamma-aminobutyric acid (GABA) agonists into the inferior colliculus, substantia nigra or medial septum.

Authors:  G D Frye; T J McCown; G R Breese
Journal:  J Pharmacol Exp Ther       Date:  1983-12       Impact factor: 4.030

10.  Multiple withdrawals from chronic ethanol "kindles" inferior collicular seizure activity: evidence for kindling of seizures associated with alcoholism.

Authors:  T J McCown; G R Breese
Journal:  Alcohol Clin Exp Res       Date:  1990-06       Impact factor: 3.455

View more
  70 in total

1.  Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala.

Authors:  Antonia Serrano; Patricia Rivera; Francisco J Pavon; Juan Decara; Juan Suárez; Fernando Rodriguez de Fonseca; Loren H Parsons
Journal:  Alcohol Clin Exp Res       Date:  2011-12-05       Impact factor: 3.455

Review 2.  Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse.

Authors:  George R Breese; Rajita Sinha; Markus Heilig
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

3.  Effects of voluntary alcohol drinking on corticotropin-releasing factor and preprodynorphin mRNA levels in the central amygdala of Sardinian alcohol-preferring rats.

Authors:  Yan Zhou; Giancarlo Colombo; Gian Luigi Gessa; Mary Jeanne Kreek
Journal:  Neurosci Lett       Date:  2013-09-08       Impact factor: 3.046

4.  Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the rat.

Authors:  Daina Economidou; Andrea Cippitelli; Serena Stopponi; Simone Braconi; Stefano Clementi; Massimo Ubaldi; Rèmi Martin-Fardon; Friedbert Weiss; Maurizio Massi; Roberto Ciccocioppo
Journal:  Alcohol Clin Exp Res       Date:  2011-01-11       Impact factor: 3.455

5.  Binge alcohol drinking elicits persistent negative affect in mice.

Authors:  Kaziya M Lee; Michal Coehlo; Hadley A McGregor; Ryan S Waltermire; Karen K Szumlinski
Journal:  Behav Brain Res       Date:  2015-06-03       Impact factor: 3.332

Review 6.  Don't stress about CRF: assessing the translational failures of CRF1antagonists.

Authors:  Samantha R Spierling; Eric P Zorrilla
Journal:  Psychopharmacology (Berl)       Date:  2017-03-07       Impact factor: 4.530

Review 7.  CRF modulation of central monoaminergic function: Implications for sex differences in alcohol drinking and anxiety.

Authors:  Kristen E Pleil; Mary Jane Skelly
Journal:  Alcohol       Date:  2018-02-02       Impact factor: 2.405

Review 8.  Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation.

Authors:  T J Phillips; C Reed; R Pastor
Journal:  Genes Brain Behav       Date:  2015-01       Impact factor: 3.449

9.  Age-related differences in anxiety-like behavior and amygdalar CCL2 responsiveness to stress following alcohol withdrawal in male Wistar rats.

Authors:  Kathryn M Harper; Darin J Knapp; Meredith A Park; George R Breese
Journal:  Psychopharmacology (Berl)       Date:  2016-09-24       Impact factor: 4.530

10.  Enhanced GABAergic transmission in the central nucleus of the amygdala of genetically selected Marchigian Sardinian rats: alcohol and CRF effects.

Authors:  Melissa A Herman; Marsida Kallupi; George Luu; Christopher S Oleata; Markus Heilig; George F Koob; Roberto Ciccocioppo; Marisa Roberto
Journal:  Neuropharmacology       Date:  2012-12-04       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.